Literature DB >> 23303970

Bullying Borrelia: when the culture of science is under attack.

Paul G Auwaerter1, Michael T Melia.   

Abstract

Although Lyme disease responds to short courses of antibiotics, tick-borne Borrelia burgdorferi has been advanced by some as a frequent explanation for medically unexplained symptoms such as continual fatigue, musculoskeletal pains, and subjective neurocognitive dysfunction. Often called "chronic Lyme disease" by adherents of this philosophy, it is loosely defined, and practitioners liberally prescribe nostrums, including prolonged antimicrobial therapies, in a belief that this eradicates suspected infection. Perhaps due to the lack of supportive data, proponents of this theory have developed their own meetings, literature, activist groups, and substantial internet activities to advance their views. Forces motivating this movement are explored, as are tactics used to advance non-scientific ideas that have included legal action and garnering legislative endorsement. While neither logical nor evidence-based, "chronic Lyme disease" harnesses corrosive energies that taint modern medicine and society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23303970      PMCID: PMC3540629     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  28 in total

1.  Wakefield was dishonest and irresponsible over MMR research, says GMC.

Authors:  Clare Dyer
Journal:  BMJ       Date:  2010-01-29

2.  A review of death certificates listing Lyme disease as a cause of death in the United States.

Authors:  Kiersten J Kugeler; Kevin S Griffith; L Hannah Gould; Ken Kochanek; Mark J Delorey; Brad J Biggerstaff; Paul S Mead
Journal:  Clin Infect Dis       Date:  2010-12-28       Impact factor: 9.079

3.  Final report of the Lyme disease review panel of the Infectious Diseases Society of America.

Authors:  Paul M Lantos; William A Charini; Gerald Medoff; Manuel H Moro; David M Mushatt; Jeffrey Parsonnet; John W Sanders; Carol J Baker
Journal:  Clin Infect Dis       Date:  2010-07-01       Impact factor: 9.079

4.  Evidence-based guidelines for the management of Lyme disease.

Authors:  Daniel Cameron; Andrea Gaito; Nick Harris; Gregory Bach; Sabra Bellovin; Kenneth Bock; Steven Bock; Joseph Burrascano; Constance Dickey; Richard Horowitz; Steven Phillips; Laurence Meer-Scherrer; Bernard Raxlen; Virginia Sherr; Harold Smith; Pat Smith; Raphael Stricker
Journal:  Expert Rev Anti Infect Ther       Date:  2004       Impact factor: 5.091

5.  Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.

Authors:  Paul G Auwaerter; Johan S Bakken; Raymond J Dattwyler; J Stephen Dumler; John J Halperin; Edward McSweegan; Robert B Nadelman; Susan O'Connell; Sunil K Sood; Arthur Weinstein; Gary P Wormser
Journal:  J Med Ethics       Date:  2010-11-21       Impact factor: 2.903

Review 6.  A critical appraisal of "chronic Lyme disease".

Authors:  Henry M Feder; Barbara J B Johnson; Susan O'Connell; Eugene D Shapiro; Allen C Steere; Gary P Wormser; W A Agger; H Artsob; P Auwaerter; J S Dumler; J S Bakken; L K Bockenstedt; J Green; R J Dattwyler; J Munoz; R B Nadelman; I Schwartz; T Draper; E McSweegan; J J Halperin; M S Klempner; P J Krause; P Mead; M Morshed; R Porwancher; J D Radolf; R P Smith; S Sood; A Weinstein; S J Wong; L Zemel
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

7.  Science, politics, and values: the politicization of professional practice guidelines.

Authors:  John D Kraemer; Lawrence O Gostin
Journal:  JAMA       Date:  2009-02-11       Impact factor: 56.272

8.  Chronic Lyme disease: the controversies and the science.

Authors:  Paul M Lantos
Journal:  Expert Rev Anti Infect Ther       Date:  2011-07       Impact factor: 5.091

9.  Science journalism: a delicate balancing act.

Authors: 
Journal:  Lancet       Date:  2011-07-30       Impact factor: 79.321

10.  The prevalence and characteristics of fibromyalgia in the general population.

Authors:  F Wolfe; K Ross; J Anderson; I J Russell; L Hebert
Journal:  Arthritis Rheum       Date:  1995-01
View more
  4 in total

Review 1.  Unorthodox alternative therapies marketed to treat Lyme disease.

Authors:  Paul M Lantos; Eugene D Shapiro; Paul G Auwaerter; Phillip J Baker; John J Halperin; Edward McSweegan; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2015-04-06       Impact factor: 9.079

Review 2.  Relevance of chronic lyme disease to family medicine as a complex multidimensional chronic disease construct: a systematic review.

Authors:  Liesbeth Borgermans; Geert Goderis; Jan Vandevoorde; Dirk Devroey
Journal:  Int J Family Med       Date:  2014-11-24

3.  New-onset panic, depression with suicidal thoughts, and somatic symptoms in a patient with a history of lyme disease.

Authors:  Amir Garakani; Andrew G Mitton
Journal:  Case Rep Psychiatry       Date:  2015-04-01

Review 4.  Novel targets and strategies to combat borreliosis.

Authors:  Martin Strnad; Libor Grubhoffer; Ryan O M Rego
Journal:  Appl Microbiol Biotechnol       Date:  2020-01-17       Impact factor: 4.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.